INTERNATIONAL PATENT: CHENGDU KANGHONG PHARMACEUTICAL CO LTD, 成都康弘药业集团股份有限公司 FILES APPLICATION FOR "INTERMEDIATE FOR SYNTHESIZING NAV1.8 INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF"

GENEVA, Feb. 2 -- CHENGDU KANGHONG PHARMACEUTICAL CO LTD (No.108 Shuxi Road, Jinniu DistrictChengdu, Sichuan 610036), 成都康弘药业集团股份有限公司 (中国四川省成都市金牛区蜀西路108号) filed a patent application (PCT/CN2025/109813) for "INTERMEDIATE FOR SYNTHESIZING NAV1.8 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF" on Jul 22, 2025. With publication no. WO/2026/021423, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is ...